Barclays’s Eastman Chemical EMN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-58,200
| Closed | -$5.86M | – | 4260 |
|
|
2021
Q3 | $5.86M | Hold |
58,200
| – | – | ﹤0.01% | 1520 |
|
|
2021
Q2 | $6.79M | Hold |
58,200
| – | – | ﹤0.01% | 1408 |
|
|
2021
Q1 | $6.41M | Buy |
58,200
+57,700
| +11,540% | +$6.27M | ﹤0.01% | 1327 |
|
|
2020
Q4 | $50K | Sell |
500
-1,000
| -67% | -$92.7K | ﹤0.01% | 4399 |
|
|
2020
Q3 | $117K | Hold |
1,500
| – | – | ﹤0.01% | 4158 |
|
|
2020
Q2 | $104K | Sell |
1,500
-7,100
| -83% | -$447K | ﹤0.01% | 4486 |
|
|
2020
Q1 | $401K | Buy |
8,600
+1,700
| +25% | +$109K | ﹤0.01% | 3763 |
|
|
2019
Q4 | $547K | Sell |
6,900
-16,500
| -71% | -$1.27M | ﹤0.01% | 4224 |
|
|
2019
Q3 | $1.73M | Buy |
23,400
+15,400
| +193% | +$1.11M | ﹤0.01% | 3048 |
|
|
2019
Q2 | $623K | Sell |
8,000
-500
| -6% | -$38K | ﹤0.01% | 4131 |
|
|
2019
Q1 | $645K | Sell |
8,500
-4,200
| -33% | -$334K | ﹤0.01% | 3870 |
|
|
2018
Q4 | $928K | Buy |
12,700
+3,000
| +31% | +$239K | ﹤0.01% | 3189 |
|
|
2018
Q3 | $928K | Buy |
9,700
+900
| +10% | +$89.2K | ﹤0.01% | 3695 |
|
|
2018
Q2 | $880K | Buy |
8,800
+3,200
| +57% | +$338K | ﹤0.01% | 3422 |
|
|
2018
Q1 | $591K | Sell |
5,600
-18,900
| -77% | -$1.91M | ﹤0.01% | 3799 |
|
|
2017
Q4 | $2.27M | Sell |
24,500
-2,700
| -10% | -$245K | ﹤0.01% | 2314 |
|
|
2017
Q3 | $2.46M | Buy |
27,200
+3,300
| +14% | +$281K | ﹤0.01% | 2142 |
|
|
2017
Q2 | $2.01M | Buy |
23,900
+4,600
| +24% | +$371K | ﹤0.01% | 2232 |
|
|
2017
Q1 | $1.56M | Sell |
19,300
-24,900
| -56% | -$1.96M | ﹤0.01% | 2322 |
|
|
2016
Q4 | $3.32M | Buy |
44,200
+16,400
| +59% | +$1.18M | ﹤0.01% | 1693 |
|
|
2016
Q3 | $1.88M | Sell |
27,800
-17,500
| -39% | -$1.17M | ﹤0.01% | 2053 |
|
|
2016
Q2 | $3.08M | Sell |
45,300
-22,400
| -33% | -$1.65M | ﹤0.01% | 1667 |
|
|
2016
Q1 | $4.87M | Buy |
67,700
+43,300
| +177% | +$2.84M | 0.01% | 1189 |
|
|
2015
Q4 | $1.64M | Sell |
24,400
-3,500
| -13% | -$245K | ﹤0.01% | 2187 |
|
|
2015
Q3 | $1.79M | Buy |
27,900
+4,000
| +17% | +$295K | ﹤0.01% | 2226 |
|
|
2015
Q2 | $1.94M | Buy |
23,900
+2,200
| +10% | +$170K | ﹤0.01% | 2244 |
|
|
2015
Q1 | $1.5M | Sell |
21,700
-9,700
| -31% | -$700K | ﹤0.01% | 2586 |
|
|
2014
Q4 | $2.35M | Sell |
31,400
-46,700
| -60% | -$3.69M | ﹤0.01% | 2378 |
|
|
2014
Q3 | $6.25M | Buy |
78,100
+53,700
| +220% | +$4.48M | 0.01% | 1574 |
|
|
2014
Q2 | $2.12M | Sell |
24,400
-1,900
| -7% | -$165K | ﹤0.01% | 2537 |
|
|
2014
Q1 | $2.26M | Sell |
26,300
-25,800
| -50% | -$2.11M | ﹤0.01% | 2431 |
|
|
2013
Q4 | $4.17M | Buy |
52,100
+3,800
| +8% | +$295K | ﹤0.01% | 1980 |
|
|
2013
Q3 | $3.72M | Buy |
48,300
+7,600
| +19% | +$585K | ﹤0.01% | 1952 |
|
|
2013
Q2 | $2.85M | Buy |
+40,700
| New | +$2.84M | ﹤0.01% | 2150 |
|
Other funds holding EMN
VPM
VCM
Barclays's EMN Position: Q1 2026 in Review
Barclays reduced its Eastman Chemical (EMN) stake by 86% in Q1 2026, selling an estimated $6.47M and leaving 14,917 shares worth $1.14M. The position accounts for ﹤0.01% of the portfolio, ranked #2676.
Barclays first reported a position in EMN in Q2 2013 and has held it in 52 quarters since. The position peaked at $52.2M in Q4 2019. 634 funds tracked by Wall St. Rank hold EMN as of Q1 2026.
- Barclays held 14,917 shares of Eastman Chemical worth $1.14M as of Q1 2026.
- Barclays sold 89,722 Eastman Chemical shares in Q1 2026, an estimated $6.47M.
- Eastman Chemical made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #2676 holding.
- Barclays first reported a position in Eastman Chemical in Q2 2013 and has held it in 52 quarters since.
- Barclays's Eastman Chemical position peaked at $52.2M in Q4 2019.
- 634 funds tracked by Wall St. Rank held Eastman Chemical as of Q1 2026.
Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.